MAI Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.09M Buy
88,480
+532
+0.6% +$43.9K 0.04% 342
2025
Q4
$7.5M Sell
87,948
-1,369
-2% -$112K 0.04% 324
2025
Q3
$6.95M Buy
89,317
+2,783
+3% +$217K 0.04% 310
2025
Q2
$6.77M Buy
86,534
+607
+0.7% +$45.3K 0.05% 289
2025
Q1
$6.23M Buy
85,927
+21,192
+33% +$1.52M 0.05% 291
2024
Q4
$4.79M Buy
64,735
+1,127
+2% +$78.9K 0.04% 325
2024
Q3
$4.2M Buy
63,608
+152
+0.2% +$11K 0.04% 277
2024
Q2
$5.86M Buy
63,456
+1,463
+2% +$130K 0.06% 237
2024
Q1
$5.92M Buy
61,993
+1,610
+3% +$135K 0.06% 227
2023
Q4
$4.6M Buy
60,383
+49,772
+469% +$3.46M 0.06% 212
2023
Q3
$735K Buy
10,611
+351
+3% +$28.2K 0.01% 515
2023
Q2
$968K Sell
10,260
-503
-5% -$43.7K 0.01% 440
2023
Q1
$890K Buy
10,763
+1,586
+17% +$125K 0.01% 454
2022
Q4
$685K Sell
9,177
-164
-2% -$12.6K 0.01% 521
2022
Q3
$772K Sell
9,341
-1,272
-12% -$122K 0.01% 427
2022
Q2
$1.01M Buy
10,613
+963
+10% +$99.7K 0.02% 373
2022
Q1
$1.14M Buy
9,650
+654
+7% +$73.4K 0.02% 372
2021
Q4
$1.17M Buy
8,996
+5,268
+141% +$614K 0.02% 380
2021
Q3
$422K Buy
3,728
+756
+25% +$86.3K 0.01% 551
2021
Q2
$308K Buy
2,972
+86
+3% +$8.11K 0.01% 593
2021
Q1
$241K Buy
2,886
+156
+6% +$13.2K 0.01% 634
2020
Q4
$249K Sell
2,730
-121
-4% -$10K 0.01% 577
2020
Q3
$228K Sell
2,851
-758
-21% -$59.1K 0.01% 524
2020
Q2
$249K Buy
3,609
+105
+3% +$7.46K 0.01% 482
2020
Q1
$220K Buy
3,504
+438
+14% +$31.6K 0.01% 481
2019
Q4
$238K Buy
3,066
+3
+0.1% +$234 0.01% 508
2019
Q3
$225K Buy
+3,063
New +$215K 0.01% 474
2019
Q2
Sell
-3,201
Closed -$204K 553
2019
Q1
$204K Buy
+3,201
New +$183K 0.01% 433

Other funds holding EW